1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

Walter T. Hughes, Donald Armstrong, Gerald P. Bodey, Arthur E. Brown, John E. Edwards, Ronald Feld, Philip Pizzo, Kenneth V I Rolston, Jerry L. Shenep, Lowell S. Young

Research output: Contribution to journalArticle

Abstract

This is the first in a series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of these guidelines is to provide assistance to clinicians when making decisions on treating the conditions specified in each guideline. The targeted providers are internists, pediatricians, and family practitioners. The targeted patients and setting for the fever and neutropenia guideline are hospitalized individuals with neutropenia secondary to cancer chemotherapy. Panel members represented experts in adult and pédiatrie infectious diseases and oncology. The guidelines are evidence-based. A standard ranking system was used for the strength of the recommendations and the quality of the evidence cited in the literature reviewed. The document has been subjected to external review by peer reviewers as well as by the Practice Guidelines Committee and was approved by the IDSA Council. An executive summary, algorithms, and tables highlight the major recommendations. The guideline will be listed on the IDSA home page at http://www.idsociety.org.

Original languageEnglish (US)
Pages (from-to)551-573
Number of pages23
JournalClinical Infectious Diseases
Volume25
Issue number3
StatePublished - 1997
Externally publishedYes

Fingerprint

Anti-Infective Agents
Fever
Guidelines
Practice Guidelines
Neutropenia
Peer Review
Communicable Diseases
Decision Making
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Immunology

Cite this

Hughes, W. T., Armstrong, D., Bodey, G. P., Brown, A. E., Edwards, J. E., Feld, R., ... Young, L. S. (1997). 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clinical Infectious Diseases, 25(3), 551-573.

1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. / Hughes, Walter T.; Armstrong, Donald; Bodey, Gerald P.; Brown, Arthur E.; Edwards, John E.; Feld, Ronald; Pizzo, Philip; Rolston, Kenneth V I; Shenep, Jerry L.; Young, Lowell S.

In: Clinical Infectious Diseases, Vol. 25, No. 3, 1997, p. 551-573.

Research output: Contribution to journalArticle

Hughes, WT, Armstrong, D, Bodey, GP, Brown, AE, Edwards, JE, Feld, R, Pizzo, P, Rolston, KVI, Shenep, JL & Young, LS 1997, '1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever', Clinical Infectious Diseases, vol. 25, no. 3, pp. 551-573.
Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clinical Infectious Diseases. 1997;25(3):551-573.
Hughes, Walter T. ; Armstrong, Donald ; Bodey, Gerald P. ; Brown, Arthur E. ; Edwards, John E. ; Feld, Ronald ; Pizzo, Philip ; Rolston, Kenneth V I ; Shenep, Jerry L. ; Young, Lowell S. / 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. In: Clinical Infectious Diseases. 1997 ; Vol. 25, No. 3. pp. 551-573.
@article{03130fc574b84746a8a6a63e3afae381,
title = "1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever",
abstract = "This is the first in a series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of these guidelines is to provide assistance to clinicians when making decisions on treating the conditions specified in each guideline. The targeted providers are internists, pediatricians, and family practitioners. The targeted patients and setting for the fever and neutropenia guideline are hospitalized individuals with neutropenia secondary to cancer chemotherapy. Panel members represented experts in adult and p{\'e}diatrie infectious diseases and oncology. The guidelines are evidence-based. A standard ranking system was used for the strength of the recommendations and the quality of the evidence cited in the literature reviewed. The document has been subjected to external review by peer reviewers as well as by the Practice Guidelines Committee and was approved by the IDSA Council. An executive summary, algorithms, and tables highlight the major recommendations. The guideline will be listed on the IDSA home page at http://www.idsociety.org.",
author = "Hughes, {Walter T.} and Donald Armstrong and Bodey, {Gerald P.} and Brown, {Arthur E.} and Edwards, {John E.} and Ronald Feld and Philip Pizzo and Rolston, {Kenneth V I} and Shenep, {Jerry L.} and Young, {Lowell S.}",
year = "1997",
language = "English (US)",
volume = "25",
pages = "551--573",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

AU - Hughes, Walter T.

AU - Armstrong, Donald

AU - Bodey, Gerald P.

AU - Brown, Arthur E.

AU - Edwards, John E.

AU - Feld, Ronald

AU - Pizzo, Philip

AU - Rolston, Kenneth V I

AU - Shenep, Jerry L.

AU - Young, Lowell S.

PY - 1997

Y1 - 1997

N2 - This is the first in a series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of these guidelines is to provide assistance to clinicians when making decisions on treating the conditions specified in each guideline. The targeted providers are internists, pediatricians, and family practitioners. The targeted patients and setting for the fever and neutropenia guideline are hospitalized individuals with neutropenia secondary to cancer chemotherapy. Panel members represented experts in adult and pédiatrie infectious diseases and oncology. The guidelines are evidence-based. A standard ranking system was used for the strength of the recommendations and the quality of the evidence cited in the literature reviewed. The document has been subjected to external review by peer reviewers as well as by the Practice Guidelines Committee and was approved by the IDSA Council. An executive summary, algorithms, and tables highlight the major recommendations. The guideline will be listed on the IDSA home page at http://www.idsociety.org.

AB - This is the first in a series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of these guidelines is to provide assistance to clinicians when making decisions on treating the conditions specified in each guideline. The targeted providers are internists, pediatricians, and family practitioners. The targeted patients and setting for the fever and neutropenia guideline are hospitalized individuals with neutropenia secondary to cancer chemotherapy. Panel members represented experts in adult and pédiatrie infectious diseases and oncology. The guidelines are evidence-based. A standard ranking system was used for the strength of the recommendations and the quality of the evidence cited in the literature reviewed. The document has been subjected to external review by peer reviewers as well as by the Practice Guidelines Committee and was approved by the IDSA Council. An executive summary, algorithms, and tables highlight the major recommendations. The guideline will be listed on the IDSA home page at http://www.idsociety.org.

UR - http://www.scopus.com/inward/record.url?scp=0031227964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031227964&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 551

EP - 573

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 3

ER -